Tricida's Future In Doubt After Renal Outcomes Failure In CKD With Metabolic Acidosis

24 Oct 2022

• By Jessica Merrill

The company's hopes to bring veverimer to market to slow chronic kidney disease progression in patients with metabolic acidosis appear to be dashed.

end of the road — Tricida may have hit the end of the road with veverimer • Source: Shutterstock

More from Clinical Trials

More from R&D